Research paperInhibition of cultured vascular smooth muscle cell migration by simvastatin (MK-733)
References (38)
- et al.
Regulation of HMG-CoA reductase
Adv. Lipid Res.
(1976) - et al.
Effects of synvinolin (MK-733) on plasma lipids in familial hypercholesterolaemia
Lancet
(1986) - et al.
Evidence for modification of lamin B by a product of mevalonic acid
J. Biol. Chem.
(1988) - et al.
Effect of lovastatin on intimal hyperplasia after balloon angioplasty: a study in an atherosclerotic hypercholesterolemic rabbit
J. Am. Coll. Cardiol.
(1991) - et al.
CS-514, a competitive inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase
Biochim. Biophys. Acta
(1986) - et al.
NB-598: a potent competitive inhibitor of squalene epoxidase
J. Biol. Chem.
(1990) - et al.
Receptor-mediated endocytosis of low-density-lipoprotein in cultured cells
Methods Enzymol.
(1983) - et al.
A new simplified single-filter assay for ‘in vitro’ evaluation of chemotaxis of 51Cr-labeled polymorphonuclear leukocytes
J. Immunol. Methods
(1989) - et al.
Protein mesurement with the Folin phenol reagent
J. Biol. Chem.
(1951) - et al.
Effect of a novel squalene epoxidase inhibitor, NB-598, on the regulation of cholesterol metabolism in Hep G2 cells
J. Biol. Chem.
(1991)
Antiatherogenic activity of FR34235 (nilvadipine), a new potent calcium antagonist
Atherosclerosis
Calcium dependency of aortic smooth muscle cell migration induced by 12-l-hydroxy-5,8,10,14-eicosatetraenoic acid
Atherosclerosis
Comparative effect of lipoxygenase products of arachidonic acid on rat aortic smooth muscle cell migration
Atherosclerosis
Smooth muscle cell migration induced by inflammatory cell products and its inhibition by a potent calcium antagonist, nilvadipine
Atherosclerosis
Bifunctional effects of transforming growth factor-β on migration of cultured rat aortic smooth muscle cells
Biochem. Biophys. Res. Commun.
Effects of simvastatin (MK-733) on branched pathway of mevalonate
Jpn. J. Pharmacol.
All ras proteins are polyisoprenylated but only some are palmitoylated
Cell
Relationship between mevalonate and mitogenesis in human fibroblasts stimulated with platelet derived growth factor
J. Biol. Chem.
Effect of fibrinogen and fibrin on the migration of vascular smooth muscle cells in vitro
Atherosclerosis
Cited by (98)
Simvastatin attenuates the additive effects of TNF-α and IL-18 on the connexin 43 up-regulation and over-proliferation of cultured aortic smooth muscle cells
2013, CytokineCitation Excerpt :They have been found to regulate inflammatory transcription factors in human endothelial and vascular SMCs and inhibit leukocyte adhesion through reducing the expression of endothelial cell adhesion molecule [15,16]. Simvastatin has been demonstrated to suppress SMC proliferation [17] and migration [18], inhibit myointimal hyperplasia following carotid artery injury [19], and prevent hypercholesterolemia and atherosclerosis in cholesterol-fed rabbits [20]. Vytorin, a combination of simvastatin and ezetimibe, is a highly efficacious, well-tolerated treatment option for hypercholesterolemic patients [21].
Lovastatin inhibits thrombospondin-1-induced smooth muscle cell chemotaxis
2011, Journal of Surgical ResearchCitation Excerpt :Furthermore, simvastatin has been shown to inhibit VSMC proliferation and uptake of aggregated cholesterol in human VSMCs [18, 19]. Evidence also exists that implicates statins in inhibition of VSMC migration [20–22]. In addition, migration and production of metalloproteinase-9 by monocytes is inhibited by statins [23].
Platelet-derived growth factor differentially regulates the expression and post-translational modification of versican by arterial smooth muscle cells through distinct protein kinase C and extracellular signal-regulated kinase pathways
2010, Journal of Biological ChemistryCitation Excerpt :HA1004 is an H7 structural analog with a 20-fold lower inhibitory potency toward PKC but with similar effects on other kinases (34). Compounds H7 and HA1004 have been used together previously to define the role of PKC in cellular processes (35, 36). All of the compounds were not overtly cell toxic because they did not increase lactate dehydrogenase release at the concentrations used in these experiments (data not shown).
Simvastatin inhibits the migration and adhesion of monocytic cells and disorganizes the cytoskeleton of activated endothelial cells
2006, European Journal of PharmacologyEffects of statins and farnesyltransferase inhibitors on the development and progression of cancer
2004, Cancer Treatment ReviewsAntioxidant effect of simvastatin is not enhanced by its association with α-tocopherol in hypercholesterolemic patients
2004, Free Radical Biology and Medicine